Search AETN
AETERNUM HEALTH, INC.
OTC · CIK 764630
Last close0.13
Daily changen/a
10 Years gain+1005.39%
Dividends TTM0
Dividend yieldn/a
Fundamental Analysis
AETN · STANDARD
SIC 3690 · Miscellaneous Electrical Machinery, Equipment & Supplies · Fiscal year end 1231
Fundamental
41.1Momentum
100.0Acceleration
100.0Confidence
81.0Annual Revenue14
Quarterly Revenue33
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality14.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 53.6616 percentage points.
Operating leverageOperating margin improved by 566.7083 percentage points.
Key Metrics
Revenue Growth TTM228.7%OK
Revenue CAGR 3Y116.36%OK
Gross Margin54.34%OK
Operating Margin-168.04%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y3.8%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $203,655.00 | $120,054.00 | -$269,274.00 | -$2,958.00 | n/a | 58.95% | -132.22% | n/a | n/a | 49.05M |
| 2025 FY Dec 31, 2024 | $65,121.00 | -$12,705.00 | -$430,489.00 | -$154,046.00 | n/a | -19.51% | -661.06% | n/a | n/a | 48.48M |
| 2024 FY Feb 29, 2024 | $19,610.00 | -$35,676.00 | -$584,240.00 | -$341,607.00 | n/a | -181.93% | -2,979.3% | n/a | n/a | 48.14M |
| 2024 FY Dec 31, 2023 | $20,109.00 | -$33,020.00 | -$552,361.00 | -$267,034.00 | n/a | -164.21% | -2,746.83% | n/a | n/a | 42.48M |
| 2024 FY Feb 28, 2023 | $22,281.00 | -$23,244.00 | -$258,524.00 | -$303,332.00 | n/a | -104.32% | -1,160.29% | n/a | n/a | 47.13M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $182,384.00 | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-024377, 0001641172-25-024714 |
| Revenue Growth TTM | 228.7% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-024377, 0001641172-25-024714 |
| Revenue CAGR 3Y | 116.36% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-014008 |
| Revenue CAGR 5Y | 109.89% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-014008 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001493152-26-014008 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-024377, 0001641172-25-024714 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 54.34% | Gross Profit / Revenue | OK | 0001493152-26-024377, 0001641172-25-024714 |
| Operating Margin | -168.04% | Operating Income / Revenue | OK | 0001493152-26-024377, 0001641172-25-024714 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 0.05x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001493152-26-024377, 0001641172-25-024714 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001493152-26-014008 |